<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00119925</url>
  </required_header>
  <id_info>
    <org_study_id>SPRING 2005-01</org_study_id>
    <secondary_id>ZonMw grant no. 945-14-116</secondary_id>
    <nct_id>NCT00119925</nct_id>
  </id_info>
  <brief_title>'SPRING'-Study: &quot;Subfertility Guidelines: Patient Related Implementation in the Netherlands Among Gynaecologists&quot;</brief_title>
  <official_title>Cost Effectiveness of Two Different Strategies to Implement the NVOG Guideline Programme on Subfertility</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Radboud University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ZonMw: The Netherlands Organisation for Health Research and Development</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Radboud University</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare two different strategies to implement the existing
      Guideline programme on Subfertility, as issued by the Dutch Society of Obstetrics and
      Gynaecology (NVOG). Therefore, an innovative patient-directed strategy will be compared to a
      control strategy and effectiveness, costs and feasibility of both strategies will be
      assessed.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Dutch Society of Obstetrics and Gynaecology (NVOG) has developed a guideline programme on
      Subfertility, including 9 guidelines concerning diagnosis and treatment of subfertility and a
      national IVF protocol.

      However, guidelines in general do not implement themselves; large gaps consists between best
      evidence (as described in the guidelines) and practice, resulting in a large variation
      between professionals.

      Our study will compare an innovative patient-directed strategy with a (minimal intervention)
      control strategy, and effectiveness, costs and feasibility of both will be assessed. We
      eventually aim at the most cost-effective strategy to implement the existing subfertility
      guideline programme.

      Please Note: In our protocol, we consider only 'couples' undergoing fertility treatment;
      therefore, we aim at gathering information from approximately 5200 records, of both male and
      female participants. When reporting eventually on their treatment, we will consider them only
      as couples, resulting in reported numbers of approximately 2600 participating couples.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2005</start_date>
  <completion_date type="Anticipated">May 2009</completion_date>
  <primary_completion_date type="Anticipated">February 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Extent of guideline adherence after approximately one year (measured by a specific set of guideline-derived indicators, formulated beforehand by the research group)</measure>
    <time_frame>half year after intervention</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Costs of both Implementation strategies</measure>
    <time_frame>half year after intervention</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Psychosocial patient characteristics after one year: fear, depression, satisfaction</measure>
    <time_frame>half year after intervention</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">5200</enrollment>
  <condition>Male Infertility</condition>
  <condition>Female Infertility</condition>
  <condition>Ovarian Hyperstimulation Syndrome</condition>
  <condition>Premature Ovarian Failure</condition>
  <condition>Endometriosis</condition>
  <arm_group>
    <arm_group_label>minimal intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>professional audit and feedback on current practice</description>
  </arm_group>
  <arm_group>
    <arm_group_label>maximal intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>multi-faceted intervention consisting of professional and patient elements</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>patient education</intervention_name>
    <description>patient leaflets about national guideline contents</description>
    <arm_group_label>maximal intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>professional audit and feedback (guideline adherence)</intervention_name>
    <description>feedback on current practice according to quality indicators</description>
    <arm_group_label>minimal intervention</arm_group_label>
    <arm_group_label>maximal intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>professional education (communication/shared decision making)</intervention_name>
    <description>educational tools for professionals concerning communication and shared decision making</description>
    <arm_group_label>maximal intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>information tools</intervention_name>
    <description>tools and checklists to improve information provision</description>
    <arm_group_label>maximal intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  each patient, male or female, visiting the OPD for a subfertility related problem or
             treatment

          -  each patient admitted to the hospital with complications of an infertility treatment

        Exclusion Criteria:

          -  patients receiving insemination with donor sperm

          -  patients receiving ICSI treatment

          -  patients who are non-Dutch speaking or understand too little Dutch to fill out the
             questionnaires
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rosella PMG Hermens, MSc, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre for Quality of Care Research</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jan AM Kremer, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Obstetrics and Gynecology, Radboud University Nijmegen Medical Centre</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Didi D Braat, Prof. MD PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Obstetrics and Gynecology, Radboud University Nijmegen Medical Centre</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Richard PT Grol, Prof. PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Centre for Quality of Care Research</affiliation>
  </overall_official>
  <overall_official>
    <last_name>E Adang</last_name>
    <role>Study Director</role>
    <affiliation>Department of Medical Technology Assessment, Radboud University Nijmegen Medical Centre</affiliation>
  </overall_official>
  <overall_official>
    <last_name>J MM van Lith, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Dutch Society of Obstetrics and Gynecology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>G Zielhuis, Prof PhD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Epidemiology and Biostatistics, Radboud University Nijmegen Medical Centre</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Selma M Mourad, MD</last_name>
    <phone>+31-24-3610590</phone>
    <email>s.mourad@kwazo.umcn.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rosella PMG Hermens, MSc, PhD</last_name>
    <phone>+31-24-3613129</phone>
    <email>R.hermens@kwazo.umcn.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Gelre Ziekenhuizen</name>
      <address>
        <city>Apeldoorn</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurens j van Dam, MD</last_name>
      <phone>+31-24-3610590</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rijnstate Ziekenhuis</name>
      <address>
        <city>Arnhem</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alex P Schmoutziguer, MD</last_name>
      <phone>+31-24-3610590</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Maasziekenhuis Pantein</name>
      <address>
        <city>Boxmeer</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ineke Minkhorst, MD</last_name>
      <phone>+31-24-3610590</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>ZBC stichting Geertgen</name>
      <address>
        <city>de Mortel</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Henk Ruis, MD</last_name>
      <phone>+31-24-3610590</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jeroen Bosch Ziekenhuis</name>
      <address>
        <city>den Bosch</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carl Hamilton, MD</last_name>
      <phone>+31-24-3610590</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Slingeland Ziekenhuis</name>
      <address>
        <city>Doetinchem</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eveline Tepe, MD</last_name>
      <phone>+31-243610590</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ziekenhuis Gelderse Vallei</name>
      <address>
        <city>Ede</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eduard Scheenjes, MD</last_name>
      <phone>+31-243610590</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Catharina Ziekenhuis</name>
      <address>
        <city>Eindhoven</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter A van Dop, MD, PhD</last_name>
      <phone>+31-243610590</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>st Antonius Ziekenhuis</name>
      <address>
        <city>Nieuwegein</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jules Schagen van Leeuwen, MD</last_name>
      <phone>+31-24-3610590</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Radboud University Nijmegen Medical Centre</name>
      <address>
        <city>Nijmegen</city>
        <zip>6500HB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan AM Kremer, MD, PhD</last_name>
      <phone>+31-24-3610590</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Canisius Wilhelmina Ziekenhuis</name>
      <address>
        <city>Nijmegen</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anton Franssen, MD</last_name>
      <phone>+31-24-3610590</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bernhoven Ziekenhuis</name>
      <address>
        <city>Oss</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jos Vollebergh, MD</last_name>
      <phone>+31-243610590</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rivierenland Ziekenhuis</name>
      <address>
        <city>Tiel</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guido Muijsers, MD</last_name>
      <phone>+31-24-3610590</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bernhoven Ziekenhuis</name>
      <address>
        <city>Veghel</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mirjam van Rozendaal, MD</last_name>
      <phone>+31-24-3610590</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Maxima Medisch Centrum</name>
      <address>
        <city>Veldhoven</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ben W Mol, MD</last_name>
      <phone>+31-24-3610590</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Streekziekenhuis Zevenaar</name>
      <address>
        <city>Zevenaar</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vincent Blom, MD</last_name>
      <phone>+31-243610590</phone>
    </contact>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>October 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 5, 2005</study_first_submitted>
  <study_first_submitted_qc>July 7, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 14, 2005</study_first_posted>
  <last_update_submitted>October 28, 2008</last_update_submitted>
  <last_update_submitted_qc>October 28, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 29, 2008</last_update_posted>
  <responsible_party>
    <name_title>J.A.M. Kremer</name_title>
    <organization>dept. of Obstetrics and Gynecology</organization>
  </responsible_party>
  <keyword>infertility</keyword>
  <keyword>guideline</keyword>
  <keyword>health care implementation</keyword>
  <keyword>intervention</keyword>
  <keyword>gynecology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Endometriosis</mesh_term>
    <mesh_term>Ovarian Hyperstimulation Syndrome</mesh_term>
    <mesh_term>Infertility, Male</mesh_term>
    <mesh_term>Primary Ovarian Insufficiency</mesh_term>
    <mesh_term>Menopause, Premature</mesh_term>
    <mesh_term>Infertility, Female</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

